Real-world outcomes of teriflunomide in relapsing–remitting multiple sclerosis: a prospective cohort study

被引：0
|
作者：
Yao Zhang
Hexiang Yin
Dingding Zhang
Yan Xu
Bin Peng
Liying Cui
机构：
[1] Center of Multiple Sclerosis and Related Disorders,Department of Neurology
[2] Peking Union Medical College Hospital,Medical Research Center
[3] Peking Union Medical College Hospital,Neurosciences Center
[4] Peking Union Medical College & Chinese Academy of Medical Sciences,undefined
[5] Peking Union Medical College Hospital,undefined
[6] Peking Union Medical College & Chinese Academy of Medical Sciences,undefined
[7] Chinese Academy of Medical Sciences,undefined
来源：
Journal of Neurology | 2022年 / 269卷
关键词：
Multiple sclerosis; Teriflunomide; Real-world; No evidence of disease activity (NEDA); Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4808 / 4816
页数：8
相关论文
共 50 条
  • [21] Teriflunomide: A Review in Relapsing-Remitting Multiple Sclerosis
    Scott, Lesley J.
    DRUGS, 2019, 79 (08) : 875 - 886
  • [22] Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece
    Efthymios Dardiotis
    Georgia Perpati
    Mariann Borsos
    Ioannis Nikolaidis
    Dimitrios Tzanetakos
    Georgia Deretzi
    Evangelos Koutlas
    Constantinos Kilidireas
    Dimos Dimitrios Mitsikostas
    Georgios Hadjigeorgiou
    Nikolaos Grigoriadis
    Neurology and Therapy, 2022, 11 : 1375 - 1390
  • [23] Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece
    Dardiotis, Efthymios
    Perpati, Georgia
    Borsos, Mariann
    Nikolaidis, Ioannis
    Tzanetakos, Dimitrios
    Deretzi, Georgia
    Koutlas, Evangelos
    Kilidireas, Constantinos
    Mitsikostas, Dimos Dimitrios
    Hadjigeorgiou, Georgios
    Grigoriadis, Nikolaos
    NEUROLOGY AND THERAPY, 2022, 11 (03) : 1375 - 1390
  • [24] Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
    Giancarlo Comi
    Carlo Pozzilli
    Vincenzo Brescia Morra
    Antonio Bertolotto
    Francesca Sangalli
    Luca Prosperini
    Antonio Carotenuto
    Pietro Iaffaldano
    Marco Capobianco
    Delia Colombo
    Mihaela Nica
    Sara Rizzoli
    Maria Trojano
    Neurological Sciences, 2020, 41 : 2843 - 2851
  • [25] Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
    Comi, Giancarlo
    Pozzilli, Carlo
    Morra, Vincenzo Brescia
    Bertolotto, Antonio
    Sangalli, Francesca
    Prosperini, Luca
    Carotenuto, Antonio
    Iaffaldano, Pietro
    Capobianco, Marco
    Colombo, Delia
    Nica, Mihaela
    Rizzoli, Sara
    Trojano, Maria
    NEUROLOGICAL SCIENCES, 2020, 41 (10) : 2843 - 2851
  • [26] Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study
    Sorensen, Per Soelberg
    Pontieri, Luigi
    Joensen, Hanna
    Heick, Alex
    Rasmussen, Peter Vestergaard
    Schafer, Jakob
    Ratzer, Rikke
    Pihl, Caroline Ellinore
    Sellebjerg, Finn
    Magyari, Melinda
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [27] The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study
    Izquierdo, Guillermo
    Damas, Fatima
    Dolores Paramo, Maria
    Luis Ruiz-Pena, Juan
    Navarro, Guillermo
    PLOS ONE, 2017, 12 (04):
  • [28] Real-World Outcomes With Cladribine Tablets in People With Relapsing Multiple Sclerosis
    Okuda, Darin
    Livingston, Terrie
    Moog, Tatum
    Smith, Alexander
    Lebson, Lori
    Piette, Elizabeth
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1100 - 1100
  • [29] Real world study of Cladribine in relapsing remitting multiple sclerosis, Kuwait experience
    Mohamed, Samar Farouk Ahmed
    Al Hashel, Jassem
    Almojel, MalaK
    Alroughani, Raed
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1105 - 1105
  • [30] Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis
    Chan, Andrew
    de Seze, Jerome
    Comabella, Manuel
    CNS DRUGS, 2016, 30 (01) : 41 - 51
12345